Driven by
Dynamism

Transforming healthcare through a forward-thinking approach and an unwavering commitment to excellence.

At Devatis Australia, we define healthcare excellence through the delivery of high-quality, globally aligned, and trusted pharmaceutical solutions tailored to Australia’s healthcare needs. Guided by a progressive and responsive mindset, we continue to support the nation’s shifting healthcare priorities.

Quality

Precision in Every Step

Our manufacturing network is built on precision, safety, and regulatory integrity.

From sourcing raw materials to delivering finished medicines, every stage is meticulously managed to maintain consistent quality. We follow globally recognised standards, including US FDA & EU GMP, to ensure that our pharmaceutical products meet the highest expectations for performance and reliability.

"At Devatis Australia, we bring together global pharmaceutical standards and local healthcare values to deliver trusted, high-quality medicines. Guided by our promise of excellence in every dose, we are committed to building lasting partnerships and advancing a healthier, more sustainable future for all."

Philipp D. Haas
Philipp D. Haas
Chairman & CEO, Devatis
Read Full Message

Vision & Mission

Our Purpose

At Devatis, our purpose is clear: to redefine standards in healthcare by delivering pharmaceutical excellence at every step.

We are driven by a commitment to provide high-quality, reliable, and innovative healthcare solutions that meet the diverse needs of patients and healthcare professionals worldwide. By focusing on precision, consistency, and patient-centric innovation, we aim to make a meaningful difference in global healthcare.

Our Core Values

Excellence

We uphold the highest standards in every aspect of our operations, from research and development to manufacturing and global distribution, ensuring superior quality in every dose.

Reliability

Consistency and trust define our approach. We deliver high-quality pharmaceutical solutions with precision, meeting the needs of healthcare professionals and patients worldwide.

Dynamism

With a proactive mindset, we continuously evolve to meet the challenges of an ever-changing healthcare landscape.

A Journey of Excellence

Since our inception, Devatis has consistently pushed boundaries, expanding its global footprint and setting new benchmarks in the pharmaceutical industry.
2007

New Zealand

DEVATIS LTD was established to market medicinal products for human use and veterinary drugs in New Zealand.

As a result of the tenders won under the DEVATIS LTD, our product portfolio in New Zealand continues to expand in various therapeutic areas.

Therapeutic Areas

  • Oncology and Hematology
  • Central Nervous System
  • Sensory Organs
  • Systemic Anti-Infectives
  • Systemic Hormonal Preparations
  • Cardiovascular System
  • Musculoskeletal System
  • Digestive System and Metabolism
Visit Website
2014

Germany

DEVATIS GmbH maintained positive growth with launches in respiratory and CNS therapy areas and also became market leader for 4 molecules in Germany.

Therapeutic Areas

  • Central Nervous System
  • Sensory Organs
  • Systemic Anti-Infectives
  • Systemic Hormonal Preparations
  • Cardiovascular System
  • Respiratory System
Visit Website
2015

USA

DEVATIS INC. is the U.S. entity of Devatis, delivering high-quality pharmaceuticals to the American market.
With a commitment to excellence in every dose, it ensures consistent quality, reliable supply, and value-added solutions.
DEVATIS INC. leverages state-of-the-art manufacturing facilities and a mature sales network to provide trusted products with on-time delivery and continuous availability across the U.S.

Therapeutic Areas

  • Oncology and Hematology
  • Sensory Organs
  • Systemic Anti-Infectives
  • Cardiovascular System
  • Musculoskeletal System
  • Respiratory System
Visit Website
2018

Switzerland

DEVATIS AG, launches its new products in Switzerland in various therapy areas, including cardiology, antibiotics, and antifungals, besides attends major congresses in oncology, hematology and nephrology. Additionally, as business development efforts persist in Europe, the position of its antifungal products in the market is strengthening, particularly in Italy.

Therapeutic Areas

  • Cardiovascular System
  • Central Nervous System
  • Oncology and Hematology
  • Systemic Hormonal Preparations
  • Systemic Anti-Infectives
  • Digestive System and Metabolism
  • Dermatology and Immunology
Visit Website
2019

Mexico

DEVATIS DE MEXICO, S.DE RL. DE C.V started its activities with its ophthalmology products in Mexico.
Ophthalmology portfolio is being made available to patients in the Mexican market, with the plan to establish the permanence of the DEVATIS DE MEXICO, S.DE RL. DE C.V brand in the country through the created structure.

Therapeutic Areas

  • Sensory Organs
Visit Website
2020

Australia

DEVATIS PTY LTD was established to market medicinal products for human use and veterinary drugs in Australia.
The development of potential strategic products is ongoing.

Therapeutic Areas

  • Central Nervous System
Visit Website
2020

Canada

DEVATIS CANADA INC. plans to strengthen its product portfolio in the country with the products in its pipeline, aiming to make the brand more active in the near future.
Visit Website
2023

Serbia

DEVATIS D.O.O. BEOGRAD, was established in 2023 to market medicinal products for human use and veterinary drugs in Serbia.
The development of potential strategic products is ongoing.
Visit Website
2024

Netherlands

DEVATIS B.V, was established in 2024 to market medicinal products for human use and veterinary drugs in the Netherlands.
The development of potential strategic products is ongoing.

Therapeutic Areas

  • Sensory Organs
  • Systemic Anti-Infectives
Visit Website
2024

Azerbaijan

DEVATIS MMC was established in 2024.

Therapeutic Areas

  • Respiratory System
  • Cardiopulmonary
  • Dermatology and Immunology
Visit Website
2025

Austria

DEVATIS GmbH is strengthening its presence in Europe with its entry into the Austrian market. Expanding our high-quality portfolio across various therapeutic areas, we continue to deliver excellence in every dose.

Therapeutic Areas

  • Central Nervous System
Visit Website
2025

UK

DEVATIS UK LTD was established in 2025 as part of Devatis’s global expansion, bringing its high standards of pharmaceutical excellence to the United Kingdom.
With a focus on quality, trust, and consistent supply, DEVATIS UK LTD aims to contribute meaningfully to the UK healthcare system through value-added, internationally compliant pharmaceutical solutions.
Building on Devatis’s established global capabilities, the UK team is dedicated to delivering reliable medicines that meet the evolving needs of healthcare professionals across the country.
Visit Website

Sustainability at Devatis Australia

At Devatis Australia, sustainability drives every decision we make — from safeguarding natural resources to supporting public health and advancing pharmaceutical progress for future generations.

Environmental
Responsibility

From reducing our carbon footprint to adopting eco-friendly manufacturing practices, we are committed to protecting the planet while delivering excellence.

Expanding Health Horizons

Our commitment to excellence transcends borders, with operations in multiple continents, including Europe, North America, Asia, and Oceania. Guided by precision, reliability, and innovation, Devatis is dedicated to shaping the future of healthcare and setting new standards in pharmaceutical excellence.

Explore Our Global Presence